ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
131 hedge funds and large institutions have $827M invested in Intra-Cellular Therapies Inc. in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 47 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
15% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 47
Holders
131
Holding in Top 10
–
Calls
$49.9M
Puts
$26.3M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$9.65M | |
| 3 | +$6.75M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$5.42M |
| 5 |
BlackRock
New York
|
+$2.89M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$8.82M | |
| 3 | -$8.68M | |
| 4 |
PC
PointState Capital
New York
|
-$8.39M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.59M |